UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 59

Sortiert nach

A Multidisciplinary Approach to Patients with Psoriasis and a History of Malignancies or On-Treatment for Solid Tumors: A Narrative Literature Review

International journal of molecular sciences, 2023-12, Vol.24 (24), p.17540

2023

Link zum Volltext

Verfügbarkeit prüfen

Ixekizumab is effective in the long-term management in moderate-to-severe plaque psoriasis: results from an Italian retrospective cohort study (the LOTIXE study)

The Journal of dermatological treatment, 2023-12, Vol.34 (1), p.2246606-2246606

2023

Link zum Volltext

Verfügbarkeit prüfen

Commentary: Unmet Needs in Generalized Pustular Psoriasis in Clinical Practice

Dermatology and therapy, 2024-01, Vol.14 (1), p.5-13

2024

Link zum Volltext

Verfügbarkeit prüfen

Interleukin-17 vs. Interleukin-23 Inhibitors in Pustular and Erythrodermic Psoriasis: A Retrospective, Multicentre Cohort Study

Journal of clinical medicine, 2023-02, Vol.12 (4), p.1662

2023

Link zum Volltext

Verfügbarkeit prüfen

PACE study: real-life Psoriasis Area and Severity Index (PASI) 100 response with biological agents in moderate-severe psoriasis

The Journal of dermatological treatment, 2018-07, Vol.29 (5), p.481-486

2018

Link zum Volltext

Verfügbarkeit prüfen

Cheilitis granulomatosa associated with lupus erythematosus discoid and treated with methotrexate: report of a case

Anais brasileiros de dermatología, 2015-06, Vol.90 (3 Suppl 1), p.200-202

2015

Link zum Volltext

Verfügbarkeit prüfen

Incidence rates of hospitalization and death from COVID-19 in patients with psoriasis receiving biological treatment: A Northern Italy experience

Journal of allergy and clinical immunology, 2021-02, Vol.147 (2), p.558-560.e1

2021

Link zum Volltext

Verfügbarkeit prüfen

Palmoplantar pustulosis successfully treated with upadacitinib: Report of three cases

Australasian journal of dermatology, 2023-11, Vol.64 (4), p.568-570

2023

Link zum Volltext

Verfügbarkeit prüfen

Mpox: an updated review of dermatological manifestations in the current outbreak

British journal of dermatology (1951), 2023-08, Vol.189 (3), p.260-270

2023

Link zum Volltext

Verfügbarkeit prüfen

Polymorphic rupioid psoriasis with chamomile‐like lesions: A case report

Journal of the European Academy of Dermatology and Venereology, 2023-06, Vol.37 (6), p.e726-e728

2023

Link zum Volltext

Verfügbarkeit prüfen

Reply to “Switch from ustekinumab to guselkumab in patients with psoriasis in real clinical practice using the “minimal disease activity” parameter”

Dermatologic therapy, 2022-08, Vol.35 (8), p.e15644-n/a

2022

Link zum Volltext

Verfügbarkeit prüfen

Real‐life effectiveness of tildrakizumab in chronic plaque psoriasis: A 52‐week multicentre retrospective study—IL PSO (Italian landscape psoriasis)

Journal of the European Academy of Dermatology and Venereology, 2023-01, Vol.37 (1), p.93-103

2023

Link zum Volltext

Verfügbarkeit prüfen

Syphilis and monkeypox co-infection: Coincidence, synergy or asymptomatic carriage?

Travel medicine and infectious disease, 2022-11, Vol.50, p.102447-102447, Article 102447

2022

Link zum Volltext

Verfügbarkeit prüfen

Genetic findings in a patient with paradoxical pyoderma gangrenosum induced by brodalumab

Clinical and experimental dermatology, 2023-03, Vol.48 (3), p.293-295

2023

Link zum Volltext

Verfügbarkeit prüfen

Long‐term proactive management of psoriasis with calcipotriol and betamethasone dipropionate foam: an Italian consensus through a combined nominal group technique and Delphi approach

International journal of dermatology, 2022-12, Vol.61 (12), p.1543-1551

2022

Link zum Volltext

Verfügbarkeit prüfen

Guselkumab: an anti-IL-23 antibody for the treatment of moderate-to-severe plaque psoriasis

EJD. European journal of dermatology, 2021-02, Vol.31 (1), p.3-16

2021

Link zum Volltext

Verfügbarkeit prüfen

Efficacy of Secukinumab in Psoriasis: Post Hoc Gender-Wise Analysis of the SUPREME Study

Clinical, cosmetic and investigational dermatology, 2023-01, Vol.16, p.27-38

2023

Link zum Volltext

Verfügbarkeit prüfen

Palmoplantar pustulosis successfully treated with upadacitinib: Report of three cases

The Australasian journal of dermatology, 2023, Vol.64 (4), p.568-570

2023

Link zum Volltext

Verfügbarkeit prüfen

Polymorphic rupioid psoriasis with chamomile-like lesions: A case report

Journal of the European Academy of Dermatology and Venereology : JEADV, 2023, Vol.37 (6), p.e726-e728

2023

Link zum Volltext

Verfügbarkeit prüfen

Effects of essential amino acid supplementation and rehabilitation on functioning in hip fracture patients: a pilot randomized controlled trial

Aging clinical and experimental research, 2019-10, Vol.31 (10), p.1517-1524

2019

Link zum Volltext

Verfügbarkeit prüfen

Clinical and dermoscopic features of atypical Spitz tumors: A multicenter, retrospective, case-control study

Journal of the American Academy of Dermatology, 2015-11, Vol.73 (5), p.777-784

2015

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 59

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(57)
Mit Volltextzugriff
(54)

Publikationsform

Artikel
(57)
Berichte
(2)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

A Multidisciplinary Approach to Patients with Psoriasis and a History of Malignancies or On-Treatment for Solid Tumors: A Narrative Literature Review

Ixekizumab is effective in the long-term management in moderate-to-severe plaque psoriasis: results from an Italian retrospective cohort study (the LOTIXE study)

Commentary: Unmet Needs in Generalized Pustular Psoriasis in Clinical Practice

Interleukin-17 vs. Interleukin-23 Inhibitors in Pustular and Erythrodermic Psoriasis: A Retrospective, Multicentre Cohort Study

Brodalumab for the treatment of plaque psoriasis in a real-life setting: a 3 years multicenter retrospective study-IL PSO (Italian landscape psoriasis)

Effectiveness, Tolerability, and Drug Survival of Risankizumab in a Real-World Setting: A Three-Year Retrospective Multicenter Study-IL PSO (ITALIAN LANDSCAPE PSORIASIS)

PACE study: real-life Psoriasis Area and Severity Index (PASI) 100 response with biological agents in moderate-severe psoriasis

Brodalumab for the Treatment of Moderate-to-Severe Psoriasis: An Expert Delphi Consensus Statement

Cheilitis granulomatosa associated with lupus erythematosus discoid and treated with methotrexate: report of a case

Incidence rates of hospitalization and death from COVID-19 in patients with psoriasis receiving biological treatment: A Northern Italy experience

Palmoplantar pustulosis successfully treated with upadacitinib: Report of three cases

Mpox: an updated review of dermatological manifestations in the current outbreak

Polymorphic rupioid psoriasis with chamomile‐like lesions: A case report

Reply to “Switch from ustekinumab to guselkumab in patients with psoriasis in real clinical practice using the “minimal disease activity” parameter”

Real‐life effectiveness of tildrakizumab in chronic plaque psoriasis: A 52‐week multicentre retrospective study—IL PSO (Italian landscape psoriasis)

Syphilis and monkeypox co-infection: Coincidence, synergy or asymptomatic carriage?

Genetic findings in a patient with paradoxical pyoderma gangrenosum induced by brodalumab

Long‐term proactive management of psoriasis with calcipotriol and betamethasone dipropionate foam: an Italian consensus through a combined nominal group technique and Delphi approach

Guselkumab: an anti-IL-23 antibody for the treatment of moderate-to-severe plaque psoriasis

Efficacy of Secukinumab in Psoriasis: Post Hoc Gender-Wise Analysis of the SUPREME Study

Palmoplantar pustulosis successfully treated with upadacitinib: Report of three cases

Polymorphic rupioid psoriasis with chamomile-like lesions: A case report

Effects of essential amino acid supplementation and rehabilitation on functioning in hip fracture patients: a pilot randomized controlled trial

Clinical and dermoscopic features of atypical Spitz tumors: A multicenter, retrospective, case-control study

Drug survival of IL-12/23, IL-17 and IL-23 inhibitors for moderate-to-severe plaque psoriasis: a retrospective multicenter real-world experience on 5932 treatment courses - IL PSO (Italian landscape psoriasis)

Suchergebnisse filtern